Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

NCT06430671 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis (RRMS)

Interventions

DRUG: CLS12311 low
DRUG: CLS12311 medium
DRUG: CLS12311 high
DRUG: uncoupled RBCs

Sponsor

Cellerys AG

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]